Table 2.
Upregulated miRNA expression profile in patients with endometrial cancer.
| Author, Year of Publication | MicroRNAs | Source | Regulation in Endometrial Cancer | Delta Patients vs. Controls |
|---|---|---|---|---|
| Roman-Canal, 2019 [56] | miR-383-5p miR-10b-5p miR-34c-3p miR-449b-5p miR-34c-5p miR-200b-3p miR-2110 miR-34b-3p |
Peritoneal lavage | Up | 0.96 0.92 0.89 0.93 0.92 0.92 0.90 0.90 |
| Jia, 2020 [57] | miR-381-3p | Endometrial specimen | Up | N/A |
| Shi, 2020 [59] | miR-133a | Endometrial specimen | Up | 0.40 |
| Fan, 2021 [61] | miR-143-3p miR-195-5p miR-20b-5p miR-204-5p miR-423-3p miR-484 |
Serum and endometrial specimen | Up | 0.75 0.95 1.12 1.03 0.68 0.79 |
| Zhou W.J., 2021 [63] | miR-15a-5p miR-106b-5p mi-R107 |
Plasma | Up | 1.02 0.50 0.25 |
N/A: not available.